Vitrolife AB Stock Nasdaq Stockholm
Equities
SE0000816043
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.6B 332M | Sales 2025 * | 3.98B 366M | Capitalization | 22.42B 2.06B |
---|---|---|---|---|---|
Net income 2024 * | 530M 48.81M | Net income 2025 * | 677M 62.34M | EV / Sales 2024 * | 6.39 x |
Net Debt 2024 * | 600M 55.26M | Net cash position 2025 * | 103M 9.51M | EV / Sales 2025 * | 5.61 x |
P/E ratio 2024 * |
42.3
x | P/E ratio 2025 * |
33.2
x | Employees | - |
Yield 2024 * |
0.82% | Yield 2025 * |
0.84% | Free-Float | 55.39% |
Latest transcript on Vitrolife AB
Managers | Title | Age | Since |
---|---|---|---|
Bronwyn Brophy
CEO | Chief Executive Officer | - | 23-07-31 |
Patrik Tolf
DFI | Director of Finance/CFO | 54 | 21-12-31 |
Chairman | 68 | 15-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 19-05-01 | |
Chairman | 68 | 15-05-06 | |
Director/Board Member | 64 | 18-04-26 |
1st Jan change | Capi. | |
---|---|---|
-9.59% | 7.67B | |
-1.20% | 5.41B | |
+26.10% | 4.62B | |
+0.02% | 4.57B | |
-53.02% | 3.22B | |
+6.42% | 2.59B | |
-8.29% | 1.79B | |
+0.42% | 1.76B | |
+4.65% | 1.62B |